Rybodyn

Seed
rybodyn.com Biotech & Healthcare San Diego, United States
Total Funding $10M
Latest Round Undisclosed Seed
Last Announced Jul 23, 2026
Investors 1 Backer
Decision Makers 5 Verified

About Rybodyn

Rybodyn is a biotechnology research company that develops therapeutics to train the immune system to detect and eradicate cancer internally.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters San Diego, United States
Tracked Since Oct 2, 2026

Web & Domain Identity

Official Website rybodyn.com
Domain Registered Date Feb 1, 2022

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Seed announced

  2. Capital Raise

    Raised $10,000,000 · Seed

    SynBioBeta

  3. Milestone

    Website domain registered

    rybodyn.com

Investors & Backers

1
IndieBio

Funding History

3 Rounds
Seed · Jul 23, 2026
Undisclosed
Seed · Mar 31, 2026
$10,000,000 SynBioBeta
Venture Round · Undisclosed
Undisclosed Source

Founders & Leadership

3

Corey Dambacher

Founder

Work email & phone locked Unlock →

Imad Ajjawi

Founder

Work email & phone locked Unlock →

Kerry Wilson

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts